Prevalence of High On-treatment Platelet Reactivity in Diabetic Patients Treated with Aspirin

Although these observations should be verified in a clinical trial, the possibility that 1 in 4 patients have HTPR with doses commonly used in diabetes could have significant implications on overall effectiveness of aspirin.